Carregant...
Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review
BACKGROUND: Despite current interest, enthusiasm and progress in the development of therapies for gastroenteropancreatic (GEP) neuroendocrine tumors (NETs), there are substantial gaps in the published literature regarding cost-of-illness analyses, economic evaluation and budget impact analyses. Comp...
Guardat en:
| Publicat a: | Ther Adv Endocrinol Metab |
|---|---|
| Autors principals: | , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6381439/ https://ncbi.nlm.nih.gov/pubmed/30815246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042018819828217 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|